Remove Acquisition Remove Enterprise Partners Remove Invest Remove Product
article thumbnail

TargeGen Acquired By Sanofi-aventis

socalTECH

TargeGen's products are also potentially useful in treating certain forms of leukemia, lymphoma, other hematological malignancies and blood disorders. Tags: targegen sanofi aventis merger acquisition lifescience bioscience. According to TargeGen, the deal's purchase price depends on the achievement of certain future milestones events.